Cartesian Therapeutics (RNAC) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to $11.5 million.
- Cartesian Therapeutics' Other Gross PP&E Adjustments rose 28295.19% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 28295.19%. This contributed to the annual value of $5.7 million for FY2024, which is 35342.28% up from last year.
- Cartesian Therapeutics' Other Gross PP&E Adjustments amounted to $11.5 million in Q3 2025, which was up 28295.19% from $10.6 million recorded in Q2 2025.
- In the past 5 years, Cartesian Therapeutics' Other Gross PP&E Adjustments registered a high of $11.5 million during Q3 2025, and its lowest value of -$6.8 million during Q4 2021.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$2.2 million (2023), whereas its average is -$132315.8.
- As far as peak fluctuations go, Cartesian Therapeutics' Other Gross PP&E Adjustments plummeted by 10448.31% in 2023, and later soared by 102450.04% in 2025.
- Over the past 5 years, Cartesian Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$6.8 million in 2021, then soared by 84.03% to -$1.1 million in 2022, then crashed by 104.48% to -$2.2 million in 2023, then soared by 353.42% to $5.7 million in 2024, then soared by 103.85% to $11.5 million in 2025.
- Its Other Gross PP&E Adjustments was $11.5 million in Q3 2025, compared to $10.6 million in Q2 2025 and $7.8 million in Q1 2025.